The Rock's filmography has been tough sledding in recent years and his latest Christmas-themed project seems to be more of ...
In a report released today, Francois Brisebois from Oppenheimer maintained a Hold rating on Ovid Therapeutics (OVID – Research Report).
The Rock can always put a wildly positive spin on any of his movies, but his latest promotional clip takes the cake: he’s ...
Greece’s Thessaloniki Film Festival ends this evening with a screening of The End, the latest feature project from the ...
Oppenheimer analyst Rick Schafer raised the firm’s price target on Nvidia (NVDA) to $175 from $150 and keeps an Outperform rating on the ...
Pure Storage edged about 4.5% higher during Wednesday trading after Oppenheimer initiated coverage on the stock with an ...
Oppenheimer's Limited-Edition Steelbook releases November 19 and comes with 4K and standard Blu-ray discs as well as a ...
Covering the data sector for Oppenheimer, analyst Param Singh is flashing ‘Buy’ signals on two specific data storage stocks.